Clinical Trial Update: Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma [Phase 4]

View source ↗

Summary

This entry reports a Phase IV clinical trial of Nimotuzumab for nasopharyngeal carcinoma. The current trial status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Biotech Pharmaceutical Co., Ltd. | Conditions: Nasopharyngeal Carcinoma | Phase 4 | Status: UNKNOWN